Common stock only | |
S&P 500 only | |
Director Only | |
10% Owner Only |
Trans Codes
Select...
Amount
-ACRS Insider Trades:
all
Unusual
Whales
Unusual Whales
Unusual Whales
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
Director
10% Owner
Mcap/AUM
2025-06-05
2025-06-09
MOLINEAUX CHRISTOPHER
A - Grant
Stock Option (Right to Buy)
42,350
$0.00
1
$161.34M
2025-05-01
2025-05-05
HALL JESSE WAYNE
Chief Medical Officer
A - Grant
Restricted Stock Units
146K
$0.00
1
$161.34M
2025-05-01
2025-05-05
HALL JESSE WAYNE
Chief Medical Officer
A - Grant
Employee Stock Option (right to buy)
510K
$0.00
1
$161.34M
2025-03-01
2025-03-04
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Common Stock
3,475
2
$161.34M
2025-03-01
2025-03-04
BALTHASER KEVIN
Chief Financial Officer
F - Tax
Common Stock
-727
$2.00
-1,454
1
$161.34M
2025-03-01
2025-03-04
MONAHAN JOSEPH
Chief Scientific Officer
F - Tax
Common Stock
-27,258
$2.00
-54,516
1
$161.34M
2025-03-01
2025-03-04
BALTHASER KEVIN
Chief Financial Officer
F - Tax
Common Stock
-727
$2.00
-1,454
1
$161.34M
2025-03-01
2025-03-04
MONAHAN JOSEPH
Chief Scientific Officer
F - Tax
Common Stock
-27,258
$2.00
-54,516
1
$161.34M
2025-03-01
2025-03-04
BALTHASER KEVIN
Chief Financial Officer
F - Tax
Common Stock
-727
$2.00
-1,454
1
$161.34M
2025-03-01
2025-03-04
MONAHAN JOSEPH
Chief Scientific Officer
F - Tax
Common Stock
-27,258
$2.00
-54,516
1
$161.34M
2025-03-01
2025-03-04
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Restricted Stock Units
-3,475
$0.00
2
$161.34M
2025-03-01
2025-03-04
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Common Stock
3,475
2
$161.34M
2025-03-01
2025-03-04
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Restricted Stock Units
-60,925
$0.00
2
$161.34M
2025-03-01
2025-03-04
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Common Stock
60,925
2
$161.34M
2025-03-01
2025-03-04
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Restricted Stock Units
-3,475
$0.00
2
$161.34M
2025-03-01
2025-03-04
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Restricted Stock Units
-60,925
$0.00
2
$161.34M
2025-03-01
2025-03-04
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Common Stock
60,925
2
$161.34M
2025-03-01
2025-03-04
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Restricted Stock Units
-3,475
$0.00
2
$161.34M
2025-03-01
2025-03-04
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Common Stock
3,475
2
$161.34M
2025-03-01
2025-03-04
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Restricted Stock Units
-60,925
$0.00
2
$161.34M
2025-03-01
2025-03-04
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Common Stock
60,925
2
$161.34M
2025-02-03
2025-02-04
WALKER NEAL
INTERIM CEO
A - Grant
Employee Stock Option (Right to Buy)
889K
$0.00
1
$161.34M
2025-02-03
2025-02-04
MONAHAN JOSEPH
Chief Scientific Officer
A - Grant
Restricted Stock Units
83,900
$0.00
1
$161.34M
2025-02-03
2025-02-04
MONAHAN JOSEPH
Chief Scientific Officer
A - Grant
Employee Stock Option (Right to Buy)
294K
$0.00
1
$161.34M
2025-02-03
2025-02-04
LOEROP JAMES
Chief Business Officer
A - Grant
Restricted Stock Units
83,500
$0.00
1
$161.34M
2025-02-03
2025-02-04
LOEROP JAMES
Chief Business Officer
A - Grant
Employee Stock Option (Right to Buy)
292K
$0.00
1
$161.34M
2025-02-03
2025-02-04
DAVIS HUGH
President and COO
A - Grant
Restricted Stock Units
74,700
$0.00
1
$161.34M
2025-02-03
2025-02-04
DAVIS HUGH
President and COO
A - Grant
Employee Stock Option (Right to Buy)
262K
$0.00
1
$161.34M
2025-02-03
2025-02-04
BALTHASER KEVIN
Chief Financial Officer
A - Grant
Restricted Stock Units
88,100
$0.00
1
$161.34M
2025-02-03
2025-02-04
BALTHASER KEVIN
Chief Financial Officer
A - Grant
Employee Stock Option (Right to Buy)
308K
$0.00
1
$161.34M
2025-02-03
2025-02-04
WALKER NEAL
INTERIM CEO
A - Grant
Employee Stock Option (Right to Buy)
889K
$0.00
1
$161.34M
2025-02-03
2025-02-04
MONAHAN JOSEPH
Chief Scientific Officer
A - Grant
Restricted Stock Units
83,900
$0.00
1
$161.34M
2025-02-03
2025-02-04
MONAHAN JOSEPH
Chief Scientific Officer
A - Grant
Employee Stock Option (Right to Buy)
294K
$0.00
1
$161.34M
2025-02-03
2025-02-04
LOEROP JAMES
Chief Business Officer
A - Grant
Restricted Stock Units
83,500
$0.00
1
$161.34M
2025-02-03
2025-02-04
LOEROP JAMES
Chief Business Officer
A - Grant
Employee Stock Option (Right to Buy)
292K
$0.00
1
$161.34M
2025-02-03
2025-02-04
DAVIS HUGH
President and COO
A - Grant
Restricted Stock Units
74,700
$0.00
1
$161.34M
2025-02-03
2025-02-04
DAVIS HUGH
President and COO
A - Grant
Employee Stock Option (Right to Buy)
262K
$0.00
1
$161.34M
2025-02-03
2025-02-04
BALTHASER KEVIN
Chief Financial Officer
A - Grant
Restricted Stock Units
88,100
$0.00
1
$161.34M
2025-02-03
2025-02-04
BALTHASER KEVIN
Chief Financial Officer
A - Grant
Employee Stock Option (Right to Buy)
308K
$0.00
1
$161.34M
2025-02-01
2025-02-04
BALTHASER KEVIN
Chief Financial Officer
F - Tax
Common Stock
-5,816
$2.00
-11,632
1
$161.34M
2025-02-01
2025-02-04
LOEROP JAMES
Chief Business Officer
F - Tax
Common Stock
-15,447
$2.00
-30,894
1
$161.34M
2025-02-01
2025-02-04
MONAHAN JOSEPH
Chief Scientific Officer
F - Tax
Common Stock
-11,317
$2.00
-22,634
1
$161.34M
2025-02-01
2025-02-04
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Restricted Stock Units
-14,750
$0.00
1
$161.34M
2025-02-01
2025-02-04
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Common Stock
14,750
1
$161.34M
2025-02-01
2025-02-04
LOEROP JAMES
Chief Business Officer
M - Exercise
Resticted Stock Units
-7,500
$0.00
1
$161.34M
2025-02-01
2025-02-04
LOEROP JAMES
Chief Business Officer
M - Exercise
Restricted Stock Units
-26,000
$0.00
2
$161.34M
2025-02-01
2025-02-04
BALTHASER KEVIN
Chief Financial Officer
F - Tax
Common Stock
-5,816
$2.00
-11,632
1
$161.34M
2025-02-01
2025-02-04
LOEROP JAMES
Chief Business Officer
F - Tax
Common Stock
-15,447
$2.00
-30,894
1
$161.34M
2025-02-01
2025-02-04
MONAHAN JOSEPH
Chief Scientific Officer
F - Tax
Common Stock
-11,317
$2.00
-22,634
1
$161.34M
2025-02-01
2025-02-04
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Restricted Stock Units
-14,750
$0.00
1
$161.34M
2025-02-01
2025-02-04
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Common Stock
14,750
1
$161.34M
2025-02-01
2025-02-04
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Restricted Stock Units
-22,250
$0.00
2
$161.34M
2025-02-01
2025-02-04
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Common Stock
22,250
2
$161.34M
2025-02-01
2025-02-04
WALKER NEAL
INTERIM CEO
M - Exercise
Restricted Stock Units
-9,467
$0.00
1
$161.34M
2025-02-01
2025-02-04
LOEROP JAMES
Chief Business Officer
M - Exercise
Resticted Stock Units
-7,500
$0.00
1
$161.34M
2025-02-01
2025-02-04
LOEROP JAMES
Chief Business Officer
M - Exercise
Restricted Stock Units
-26,000
$0.00
2
$161.34M
2025-02-01
2025-02-04
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Restricted Stock Units
-22,250
$0.00
2
$161.34M
2025-02-01
2025-02-04
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Common Stock
22,250
2
$161.34M
2025-02-01
2025-02-04
WALKER NEAL
INTERIM CEO
M - Exercise
Restricted Stock Units
-9,467
$0.00
1
$161.34M
2025-01-02
2025-01-03
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Restricted Stock Units
-17,380
$0.00
1
$161.34M
2025-01-02
2025-01-03
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Common Stock
17,380
1
$161.34M
2025-01-02
2025-01-03
WALKER NEAL
INTERIM CEO
M - Exercise
Restricted Stock Units
-29,149
$0.00
1
$161.34M
2025-01-02
2025-01-03
LOEROP JAMES
Chief Business Officer
F - Tax
Common Stock
-8,575
$2.00
-17,150
1
$161.34M
2025-01-02
2025-01-03
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Common Stock
17,380
1
$161.34M
2025-01-02
2025-01-03
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Restricted Stock Units
-17,380
$0.00
1
$161.34M
2025-01-02
2025-01-03
LOEROP JAMES
Chief Business Officer
M - Exercise
Restricted Stock Units
-18,150
$0.00
1
$161.34M
2025-01-02
2025-01-03
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Common Stock
13,200
1
$161.34M
2025-01-02
2025-01-03
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Restricted Stock Units
-13,200
$0.00
1
$161.34M
2025-01-02
2025-01-03
LOEROP JAMES
Chief Business Officer
A - Grant
Restricted Stock Units
55,000
$0.00
1
$161.34M
2025-01-02
2025-01-03
MONAHAN JOSEPH
Chief Scientific Officer
A - Grant
Restricted Stock Units
52,667
$0.00
1
$161.34M
2025-01-02
2025-01-03
WALKER NEAL
INTERIM CEO
M - Exercise
Restricted Stock Units
-29,149
$0.00
1
$161.34M
2025-01-02
2025-01-03
BALTHASER KEVIN
Chief Financial Officer
A - Grant
Restricted Stock Units
40,000
$0.00
1
$161.34M
2025-01-02
2025-01-03
BALTHASER KEVIN
Chief Financial Officer
A - Grant
Restricted Stock Units
40,000
$0.00
1
$161.34M
2025-01-02
2025-01-03
LOEROP JAMES
Chief Business Officer
A - Grant
Restricted Stock Units
55,000
$0.00
1
$161.34M
2025-01-02
2025-01-03
MONAHAN JOSEPH
Chief Scientific Officer
A - Grant
Restricted Stock Units
52,667
$0.00
1
$161.34M
2025-01-02
2025-01-03
BALTHASER KEVIN
Chief Financial Officer
F - Tax
Common Stock
-5,059
$2.00
-10,118
1
$161.34M
2025-01-02
2025-01-03
BALTHASER KEVIN
Chief Financial Officer
A - Grant
Restricted Stock Units
40,000
$0.00
1
$161.34M
2025-01-02
2025-01-03
LOEROP JAMES
Chief Business Officer
A - Grant
Restricted Stock Units
55,000
$0.00
1
$161.34M
2025-01-02
2025-01-03
MONAHAN JOSEPH
Chief Scientific Officer
A - Grant
Restricted Stock Units
52,667
$0.00
1
$161.34M
2025-01-02
2025-01-03
BALTHASER KEVIN
Chief Financial Officer
F - Tax
Common Stock
-5,059
$2.00
-10,118
1
$161.34M
2025-01-02
2025-01-03
LOEROP JAMES
Chief Business Officer
F - Tax
Common Stock
-8,575
$2.00
-17,150
1
$161.34M
2025-01-02
2025-01-03
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Restricted Stock Units
-13,200
$0.00
1
$161.34M
2025-01-02
2025-01-03
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Common Stock
13,200
1
$161.34M
2025-01-02
2025-01-03
LOEROP JAMES
Chief Business Officer
M - Exercise
Restricted Stock Units
-18,150
$0.00
1
$161.34M
2025-01-02
2025-01-03
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Restricted Stock Units
-17,380
$0.00
1
$161.34M
2025-01-02
2025-01-03
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Common Stock
17,380
1
$161.34M
2025-01-02
2025-01-03
WALKER NEAL
INTERIM CEO
M - Exercise
Restricted Stock Units
-29,149
$0.00
1
$161.34M
2025-01-02
2025-01-03
BALTHASER KEVIN
Chief Financial Officer
F - Tax
Common Stock
-5,059
$2.00
-10,118
1
$161.34M
2025-01-02
2025-01-03
LOEROP JAMES
Chief Business Officer
F - Tax
Common Stock
-8,575
$2.00
-17,150
1
$161.34M
2025-01-02
2025-01-03
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Restricted Stock Units
-13,200
$0.00
1
$161.34M
2025-01-02
2025-01-03
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Common Stock
13,200
1
$161.34M
2025-01-02
2025-01-03
LOEROP JAMES
Chief Business Officer
M - Exercise
Restricted Stock Units
-18,150
$0.00
1
$161.34M
2025-01-01
2025-01-03
BALTHASER KEVIN
Chief Financial Officer
F - Tax
Common Stock
-2,430
$2.00
-4,860
1
$161.34M
2025-01-01
2025-01-03
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Restricted Stock Units
-7,500
$0.00
1
$161.34M
2025-01-01
2025-01-03
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Common Stock
7,500
1
$161.34M
2025-01-01
2025-01-03
WALKER NEAL
INTERIM CEO
M - Exercise
Restricted Stock Units
-9,467
$0.00
1
$161.34M
2024-12-31
2025-01-03
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Common Stock
73,750
1
$161.34M
2024-12-31
2025-01-03
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Restricted Stock Units
-73,750
$0.00
1
$161.34M
2024-12-31
2025-01-03
LOEROP JAMES
Chief Business Officer
M - Exercise
Restricted Stock Units
-73,750
$0.00
1
$161.34M
2024-12-31
2025-01-03
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Common Stock
73,750
1
$161.34M
2024-12-31
2025-01-03
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Restricted Stock Units
-73,750
$0.00
1
$161.34M
2024-12-31
2025-01-03
LOEROP JAMES
Chief Business Officer
F - Tax
Common Stock
-32,089
$2.00
-64,178
1
$161.34M
2024-12-31
2025-01-03
BALTHASER KEVIN
Chief Financial Officer
F - Tax
Common Stock
-30,732
$2.00
-61,464
1
$161.34M
2024-12-10
2024-12-12
MONAHAN JOSEPH
Chief Scientific Officer
G - Gift
Common Stock
-15,000
$0.00
1
$161.34M
2024-12-04
2024-12-06
WALKER NEAL
INTERIM CEO
M - Exercise
Employee Stock Option (right to buy)
-119K
$0.00
1
$161.34M
2024-12-02
2024-12-03
DAVIS HUGH
President and COO
A - Grant
Employee Stock Option (Right to Buy)
375K
$0.00
1
$161.34M
2024-12-02
2024-12-03
DAVIS HUGH
President and COO
A - Grant
Restricted Stock Units
107K
$0.00
1
$161.34M
2024-12-01
2024-12-03
WALKER NEAL
INTERIM CEO
M - Exercise
Restricted Stock Units
-9,466
$0.00
1
$161.34M
2024-11-01
2024-11-05
WALKER NEAL
INTERIM PRESIDENT AND CEO
F - Tax
Common Stock
-2,721
$2.00
-5,442
1
$161.34M
2024-11-01
2024-11-05
WALKER NEAL
INTERIM PRESIDENT AND CEO
M - Exercise
Restricted Stock Units
-9,467
$0.00
1
$161.34M
2024-10-01
2024-10-03
WALKER NEAL
INTERIM PRESIDENT AND CEO
M - Exercise
Restricted Stock Units
-9,467
$0.00
1
$161.34M
2024-10-01
2024-10-03
WALKER NEAL
INTERIM PRESIDENT AND CEO
F - Tax
Common Stock
-2,722
$1.00
-2,722
1
$161.34M
2024-09-01
2024-09-04
WALKER NEAL
INTERIM PRESIDENT AND CEO
F - Tax
Common Stock
-2,722
$1.00
-2,722
1
$161.34M
2024-09-01
2024-09-04
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Restricted Stock Units
-1,000
$0.00
1
$161.34M
2024-09-01
2024-09-04
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Common Stock
1,000
1
$161.34M
2024-09-01
2024-09-04
WALKER NEAL
INTERIM PRESIDENT AND CEO
M - Exercise
Restricted Stock Units
-9,466
$0.00
1
$161.34M
2024-09-01
2024-09-04
BALTHASER KEVIN
Chief Financial Officer
F - Tax
Common Stock
-286
$1.00
-286
1
$161.34M
2024-08-09
2024-08-13
WALKER NEAL
INTERIM PRESIDENT AND CEO
M - Exercise
Common Stock
43,548
$1.00
43,548
1
$161.34M
2024-08-09
2024-08-13
WALKER NEAL
INTERIM PRESIDENT AND CEO
M - Exercise
Employee Stock Option (right to buy)
-43,548
$0.00
1
$161.34M
2024-08-01
2024-08-05
WALKER NEAL
INTERIM PRESIDENT AND CEO
F - Tax
Common Stock
-2,722
$1.00
-2,722
1
$161.34M
2024-08-01
2024-08-05
WALKER NEAL
INTERIM PRESIDENT AND CEO
M - Exercise
Restricted Stock Units
-9,467
$0.00
1
$161.34M
2024-07-01
2024-07-03
WALKER NEAL
INTERIM PRESIDENT AND CEO
F - Tax
Common Stock
-2,722
$1.00
-2,722
1
$161.34M
2024-07-01
2024-07-03
WALKER NEAL
INTERIM PRESIDENT AND CEO
M - Exercise
Restricted Stock Units
-9,467
$0.00
1
$161.34M
2024-06-06
2024-06-10
MOLINEAUX CHRISTOPHER
A - Grant
Stock Option (Right to Buy)
15,750
$0.00
1
$161.34M
2024-06-01
2024-06-04
WALKER NEAL
INTERIM PRESIDENT AND CEO
F - Tax
Common Stock
-2,722
$1.00
-2,722
1
$161.34M
2024-06-01
2024-06-04
POWELL ANDREW KENNETH WILLIAM
M - Exercise
Restricted Stock Units
-4,660
$0.00
1
$161.34M
2024-06-01
2024-06-04
WALKER NEAL
INTERIM PRESIDENT AND CEO
M - Exercise
Restricted Stock Units
-9,466
$0.00
1
$161.34M
2024-05-01
2024-05-03
WALKER NEAL
INTERIM PRESIDENT AND CEO
F - Tax
Common Stock
-2,784
$1.00
-2,784
1
$161.34M
2024-05-01
2024-05-03
WALKER NEAL
INTERIM PRESIDENT AND CEO
M - Exercise
Restricted Stock Units
-9,467
$0.00
1
$161.34M
2024-04-01
2024-04-03
WALKER NEAL
INTERIM PRESIDENT AND CEO
F - Tax
Common Stock
-3,224
$1.00
-3,224
1
$161.34M
2024-04-01
2024-04-03
WALKER NEAL
INTERIM PRESIDENT AND CEO
M - Exercise
Restricted Stock Units
-9,467
$0.00
1
$161.34M
2024-03-04
2024-03-05
POWELL ANDREW KENNETH WILLIAM
P - Purchase
Common Stock
6,000
$1.00
6,000
1
$161.34M
2024-03-02
2024-03-05
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Restricted Stock Units
-12,500
$0.00
1
$161.34M
2024-03-02
2024-03-05
BALTHASER KEVIN
Chief Financial Officer
F - Tax
Common Stock
-427
$1.00
-427
1
$161.34M
2024-03-02
2024-03-05
MONAHAN JOSEPH
Chief Scientific Officer
F - Tax
Common Stock
-3,531
$1.00
-3,531
1
$161.34M
2024-03-02
2024-03-05
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Restricted Stock Units
-1,500
$0.00
1
$161.34M
2024-03-02
2024-03-05
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Common Stock
1,500
1
$161.34M
2024-03-02
2024-03-05
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Common Stock
12,500
1
$161.34M
2024-03-01
2024-03-05
WALKER NEAL
Interim President and CEO
M - Exercise
Restricted Stock Units
-9,466
$0.00
1
$161.34M
2024-03-01
2024-03-05
POWELL ANDREW KENNETH WILLIAM
P - Purchase
Common Stock
8,500
$1.00
8,500
1
$161.34M
2024-03-01
2024-03-05
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Common Stock
60,925
2
$161.34M
2024-03-01
2024-03-05
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Restricted Stock Units
-60,925
$0.00
2
$161.34M
2024-03-01
2024-03-05
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Common Stock
3,475
2
$161.34M
2024-03-01
2024-03-05
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Restricted Stock Units
-3,475
$0.00
2
$161.34M
2024-03-01
2024-03-05
MONAHAN JOSEPH
Chief Scientific Officer
F - Tax
Common Stock
-17,752
$1.00
-17,752
2
$161.34M
2024-03-01
2024-03-05
WALKER NEAL
Interim President and CEO
F - Tax
Common Stock
-3,223
$1.00
-3,223
1
$161.34M
2024-03-01
2024-03-05
BALTHASER KEVIN
Chief Financial Officer
F - Tax
Common Stock
-990
$1.00
-990
2
$161.34M
2024-02-01
2024-02-05
BALTHASER KEVIN
Chief Financial Officer
A - Grant
Employee Stock Option (Right to Buy)
207K
$0.00
1
$161.34M
2024-02-01
2024-02-05
BALTHASER KEVIN
Chief Financial Officer
A - Grant
Restricted Stock Units
207K
$0.00
2
$161.34M
2024-02-01
2024-02-05
LOEROP JAMES
Chief Business Officer
A - Grant
Employee Stock Option (Right to Buy)
207K
$0.00
1
$161.34M
2024-02-01
2024-02-05
LOEROP JAMES
Chief Business Officer
A - Grant
Restricted Stock Units
207K
$0.00
2
$161.34M
2024-02-01
2024-02-05
MONAHAN JOSEPH
Chief Scientific Officer
A - Grant
Employee Stock Option (Right to Buy)
207K
$0.00
1
$161.34M
2024-02-01
2024-02-05
MONAHAN JOSEPH
Chief Scientific Officer
A - Grant
Restricted Stock Units
207K
$0.00
2
$161.34M
2024-02-01
2024-02-05
WALKER NEAL
Interim CEO
A - Grant
Stock Option (Right to Buy)
497K
$0.00
1
$161.34M
2024-02-01
2024-02-05
LOEROP JAMES
Chief Business Officer
F - Tax
Common Stock
-6,421
$1.00
-6,421
2
$161.34M
2024-02-01
2024-02-05
MONAHAN JOSEPH
Chief Scientific Officer
F - Tax
Common Stock
-2,583
$1.00
-2,583
1
$161.34M
2024-02-01
2024-02-05
LOEROP JAMES
Chief Business Officer
M - Exercise
Restricted Stock Unit
-7,500
$0.00
1
$161.34M
2024-02-01
2024-02-05
LOEROP JAMES
Chief Business Officer
M - Exercise
Restricted Stock Units
-11,250
$0.00
1
$161.34M
2024-02-01
2024-02-05
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Restricted Stock Unit
-7,500
$0.00
1
$161.34M
2024-02-01
2024-02-05
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Common Stock
7,500
1
$161.34M
2024-01-01
2024-01-03
BALTHASER KEVIN
Chief Financial Officer
F - Tax
Common Stock
-2,536
$1.00
-2,536
1
$161.34M
2024-01-01
2024-01-03
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Restricted Stock Units
-7,500
$0.00
1
$161.34M
2024-01-01
2024-01-03
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Common Stock
7,500
1
$161.34M
2024-01-01
2024-01-03
MANION DOUGLAS
Pres and CEO
M - Exercise
Restricted Stock Units
-27,000
$0.00
1
$161.34M
2023-10-23
2023-10-25
MONAHAN JOSEPH
Chief Scientific Officer
S - Sale
Common Stock
-6,000
$5.00
-30,000
1
$161.34M
2023-09-06
2023-09-07
BALTHASER KEVIN
Chief Financial Officer
P - Purchase
Common Stock
9,490
$8.00
75,920
1
$161.34M
2023-09-01
2023-09-05
BALTHASER KEVIN
Chief Financial Officer
F - Tax
Common Stock
-285
$8.00
-2,280
1
$161.34M
2023-09-01
2023-09-05
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Restricted Stock Units
-1,000
$0.00
1
$161.34M
2023-09-01
2023-09-05
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Common Stock
1,000
1
$161.34M
2023-08-28
2023-08-28
LOEROP JAMES
Chief Business Officer
P - Purchase
Common Stock
14,705
$7.00
103K
1
$161.34M
2023-08-21
2023-08-22
MONAHAN JOSEPH
Chief Scientific Officer
S - Sale
Common Stock
-6,000
$7.00
-42,000
1
$161.34M
2023-08-01
2023-08-03
MANION DOUGLAS
Pres and CEO
M - Exercise
Restricted Stock Units
-15,575
$0.00
1
$161.34M
2023-07-01
2023-07-05
CAWKWELL GAIL
Chief Medical Officer
F - Tax
Common Stock
-5,407
$10.00
-54,070
1
$161.34M
2023-07-01
2023-07-05
CAWKWELL GAIL
Chief Medical Officer
M - Exercise
Restricted Stock Units
-15,000
$0.00
1
$161.34M
2023-06-20
2023-06-22
MOLINEAUX CHRISTOPHER
M - Exercise
Stock Option (right to buy)
-16,500
$0.00
1
$161.34M
2023-06-20
2023-06-22
MONAHAN JOSEPH
Chief Scientific Officer
S - Sale
Common Stock
-6,000
$10.00
-60,000
1
$161.34M
2023-06-15
2023-06-20
MOLINEAUX CHRISTOPHER
M - Exercise
Stock Option (right to buy)
-249
$0.00
2
$161.34M
2023-06-02
2023-06-05
POWELL ANDREW KENNETH WILLIAM
M - Exercise
Restricted Stock Units
-4,507
$0.00
1
$161.34M
2023-06-01
2023-06-05
POWELL ANDREW KENNETH WILLIAM
A - Grant
Restricted Stock Units
4,660
$0.00
1
$161.34M
2023-06-01
2023-06-05
MOLINEAUX CHRISTOPHER
A - Grant
Stock Option (Right to Buy)
15,750
$0.00
1
$161.34M
2023-06-01
2023-06-05
POWELL ANDREW KENNETH WILLIAM
A - Grant
Stock Option (Right to Buy)
15,750
$0.00
1
$161.34M
2023-03-03
2023-03-03
BALTHASER KEVIN
Chief Financial Officer
S - Sale
Common Stock
-894
$13.00
-11,622
1
$161.34M
2023-03-03
2023-03-03
MONAHAN JOSEPH
Chief Scientific Officer
S - Sale
Common Stock
-16,037
$13.00
-208K
1
$161.34M
2023-03-02
2023-03-03
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Common Stock
12,500
1
$161.34M
2023-03-02
2023-03-03
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Restricted Stock Units
-12,500
$0.00
1
$161.34M
2023-03-02
2023-03-03
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Common Stock
1,500
1
$161.34M
2023-03-02
2023-03-03
BALTHASER KEVIN
Chief Financial Officer
S - Sale
Common Stock
-1,000
$12.00
-12,000
1
$161.34M
2023-03-02
2023-03-03
MONAHAN JOSEPH
Chief Scientific Officer
S - Sale
Common Stock
-14,800
$12.00
-178K
1
$161.34M
2023-03-02
2023-03-03
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Restricted Stock Units
-1,500
$0.00
1
$161.34M
2023-03-01
2023-03-03
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Common Stock
74,675
3
$161.34M
2023-03-01
2023-03-03
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Restricted Stock Units
-4,950
$0.00
3
$161.34M
2023-03-01
2023-03-03
BALTHASER KEVIN
Chief Financial Officer
M - Exercise
Common Stock
4,950
3
$161.34M
2023-03-01
2023-03-03
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Restricted Stock Units
-74,675
$0.00
3
$161.34M
2023-02-15
2023-02-17
MONAHAN JOSEPH
Chief Scientific Officer
S - Sale
Common Stock
-5,000
$13.00
-65,000
1
$161.34M
2023-02-08
2023-02-10
LOEROP JAMES
Chief Business Officer
S - Sale
Common Stock
-4,267
$14.00
-59,738
1
$161.34M
2023-02-01
2023-02-03
MONAHAN JOSEPH
Chief Scientific Officer
A - Grant
Employee Stock Option (Right to Buy)
105K
$0.00
1
$161.34M
2023-02-01
2023-02-03
MONAHAN JOSEPH
Chief Scientific Officer
A - Grant
Restricted Stock Units
30,000
$0.00
1
$161.34M
2023-02-01
2023-02-03
CAWKWELL GAIL
Chief Medical Officer
A - Grant
Restricted Stock Units
30,000
$0.00
1
$161.34M
2023-02-01
2023-02-03
CAWKWELL GAIL
Chief Medical Officer
A - Grant
Employee Stock Option (Right to Buy)
105K
$0.00
1
$161.34M
2023-02-01
2023-02-03
BALTHASER KEVIN
Chief Financial Officer
A - Grant
Restricted Stock Units
30,000
$0.00
1
$161.34M
2023-02-01
2023-02-03
BALTHASER KEVIN
Chief Financial Officer
A - Grant
Employee Stock Option (Right to Buy)
105K
$0.00
1
$161.34M
2023-02-01
2023-02-03
LOEROP JAMES
Chief Business Officer
M - Exercise
Restricted Stock Units
-11,250
$0.00
1
$161.34M
2023-02-01
2023-02-03
LOEROP JAMES
Chief Business Officer
A - Grant
Employee Stock Option (Right to Buy)
105K
$0.00
1
$161.34M
2023-02-01
2023-02-03
LOEROP JAMES
Chief Business Officer
A - Grant
Restricted Stock Units
30,000
$0.00
1
$161.34M
2023-02-01
2023-02-03
MANION DOUGLAS
Pres and CEO
A - Grant
Employee Stock Option (Right to Buy)
378K
$0.00
1
$161.34M
2022-12-15
2022-12-16
MONAHAN JOSEPH
Chief Scientific Officer
S - Sale
Common Stock
-5,000
$16.00
-80,000
1
$161.34M
2022-10-17
2022-10-19
MONAHAN JOSEPH
Chief Scientific Officer
S - Sale
Common Stock
-5,000
$16.00
-80,000
1
$161.34M
2022-08-01
2022-08-02
MANION DOUGLAS
Pres and COO
A - Grant
Restricted Stock Units
62,300
$0.00
1
$161.34M
2022-08-01
2022-08-02
MANION DOUGLAS
Pres and COO
A - Grant
Employee Stock Option (Right to Buy)
218K
$0.00
1
$161.34M
2022-07-01
2022-07-05
CAWKWELL GAIL
Chief Medical Officer
A - Grant
Employee Stock Option (Right to Buy)
210K
$0.00
1
$161.34M
2022-07-01
2022-07-05
CAWKWELL GAIL
Chief Medical Officer
A - Grant
Restricted Stock Units
60,000
$0.00
1
$161.34M
2022-06-03
2022-06-06
POWELL ANDREW KENNETH WILLIAM
M - Exercise
Restricted Stock Units
-3,356
$0.00
1
$161.34M
2022-06-02
2022-06-06
MOLINEAUX CHRISTOPHER
A - Grant
Stock Option (Right to Buy)
15,750
$0.00
1
$161.34M
2022-06-02
2022-06-06
POWELL ANDREW KENNETH WILLIAM
A - Grant
Restricted Stock Units
4,507
$0.00
1
$161.34M
2022-06-02
2022-06-06
POWELL ANDREW KENNETH WILLIAM
A - Grant
Stock Option (Right to Buy)
15,750
$0.00
1
$161.34M
2022-04-18
2022-04-20
MONAHAN JOSEPH
Chief Scientific Officer
S - Sale
Common Stock
-30,000
$16.00
-480K
1
$161.34M
2022-03-10
2022-03-14
MONAHAN JOSEPH
Chief Scientific Officer
S - Sale
Common Stock
-27,165
$16.00
-435K
1
$161.34M
2022-03-10
2022-03-14
RUFFO FRANK
Chief Financial Officer
S - Sale
Common Stock
-12,823
$16.00
-205K
1
$161.34M
2022-03-02
2022-03-03
RUFFO FRANK
Chief Financial Officer
M - Exercise
Restricted stock units
-8,297
$0.00
1
$161.34M
2022-03-02
2022-03-03
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Restricted stock units
-12,500
$0.00
1
$161.34M
2022-03-02
2022-03-03
WALKER NEAL
President and CEO
M - Exercise
Restricted stock units
-18,254
$0.00
1
$161.34M
2022-03-02
2022-03-03
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Common Stock
12,500
1
$161.34M
2022-03-01
2022-03-03
RUFFO FRANK
Chief Financial Officer
A - Grant
Employee Stock Option (Right to Buy)
155K
$0.00
1
$161.34M
2022-03-01
2022-03-03
MONAHAN JOSEPH
Chief Scientific Officer
A - Grant
Employee Stock Option (Right to Buy)
153K
$0.00
1
$161.34M
2022-03-01
2022-03-03
MONAHAN JOSEPH
Chief Scientific Officer
A - Grant
Restricted stock units
43,700
$0.00
1
$161.34M
2022-03-01
2022-03-03
RUFFO FRANK
Chief Financial Officer
A - Grant
Restricted stock units
44,300
$0.00
1
$161.34M
2022-03-01
2022-03-03
WALKER NEAL
President and CEO
A - Grant
Employee Stock Option (Right to Buy)
336K
$0.00
1
$161.34M
2022-03-01
2022-03-03
WALKER NEAL
President and CEO
A - Grant
Restricted stock units
96,000
$0.00
1
$161.34M
2022-03-01
2022-03-03
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Restricted stock units
-63,750
$0.00
2
$161.34M
2022-03-01
2022-03-03
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Common Stock
63,750
2
$161.34M
2022-03-01
2022-03-03
RUFFO FRANK
Chief Financial Officer
M - Exercise
Restricted stock units
-34,050
$0.00
2
$161.34M
2022-03-01
2022-03-03
WALKER NEAL
President and CEO
M - Exercise
Restricted stock units
-114K
$0.00
2
$161.34M
2022-02-09
2022-02-11
MONAHAN JOSEPH
Chief Scientific Officer
S - Sale
Common Stock
-383
$13.00
-4,979
1
$161.34M
2022-02-09
2022-02-11
RUFFO FRANK
Chief Financial Officer
S - Sale
Common Stock
-1,388
$13.00
-18,044
1
$161.34M
2022-02-09
2022-02-11
WALKER NEAL
President and CEO
S - Sale
Common Stock
-3,595
$13.00
-46,735
1
$161.34M
2022-02-01
2022-02-03
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Restricted Stock Units
-1,050
$0.00
1
$161.34M
2022-02-01
2022-02-03
WALKER NEAL
President and CEO
M - Exercise
Restricted Stock Units
-10,800
$0.00
1
$161.34M
2022-02-01
2022-02-03
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Common Stock
1,050
1
$161.34M
2022-02-01
2022-02-03
RUFFO FRANK
Chief Financial Officer
M - Exercise
Restricted Stock Units
-3,875
$0.00
1
$161.34M
2022-02-01
2022-02-01
LOEROP JAMES
Chief Business Officer
A - Grant
Restricted Stock Units
45,000
$0.00
1
$161.34M
2022-02-01
2022-02-01
LOEROP JAMES
Chief Business Officer
A - Grant
Employee Stock Option (Right to Buy)
155K
$0.00
1
$161.34M
2022-01-03
2022-01-05
ALI-JACKSON KAMIL
Chief Legal Officer
M - Exercise
Restricted Stock Unit
-6,638
$0.00
1
$161.34M
2022-01-03
2022-01-05
ALI-JACKSON KAMIL
Chief Legal Officer
M - Exercise
Restricted Stock Units
-38,880
$0.00
3
$161.34M
2021-03-11
2021-11-22
ALI-JACKSON KAMIL
Chief Legal Officer
G - Gift
Common Stock
-7,500
$0.00
1
$161.34M
2021-11-01
2021-11-03
FORESITE CAPITAL MANAGEMENT III, LLC
J - Other
Common Stock
8,276
$0.00
1
$161.34M
2021-11-01
2021-11-03
FORESITE CAPITAL MANAGEMENT III, LLC
J - Other
Common Stock
-1.95M
$0.00
1
$161.34M
2021-09-01
2021-09-02
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Restricted Stock Units
-2,333
$0.00
1
$161.34M
2021-09-01
2021-09-02
MONAHAN JOSEPH
Chief Scientific Officer
F - Tax
Common Stock
-1,041
$17.00
-17,697
1
$161.34M
2021-09-01
2021-09-02
MONAHAN JOSEPH
Chief Scientific Officer
M - Exercise
Common Stock
2,333
1
$161.34M
2021-07-13
2021-07-14
GORDON DAVID
Chief Medical Officer
S - Sale
Common Stock
-2,631
$17.00
-44,727
1
$161.34M
2021-07-02
2021-07-07
GORDON DAVID
Chief Medical Officer
M - Exercise
Restricted Stock Units
-6,000
$0.00
1
$161.34M
2021-06-03
2021-06-04
ALI-JACKSON KAMIL
Chief Legal Officer
S - Sale
Common Stock
-9,492
$22.00
-209K
1
$161.34M
2021-06-03
2021-06-04
MOLINEAUX CHRISTOPHER
A - Grant
Stock Option (Right to Buy)
12,250
$0.00
1
$161.34M
2021-06-03
2021-06-04
POWELL ANDREW KENNETH WILLIAM
A - Grant
Restricted Stock Units
3,356
$0.00
1
$161.34M
2021-06-03
2021-06-04
POWELL ANDREW KENNETH WILLIAM
A - Grant
Stock Option (Right to Buy)
12,250
$0.00
1
$161.34M
2021-06-02
2021-06-02
ALI-JACKSON KAMIL
Chief Legal Officer
S - Sale
Common Stock
-30,119
$22.00
-663K
4
$161.34M
2021-06-02
2021-06-02
GORDON DAVID
Chief Medical Officer
S - Sale
Common Stock
-37,914
$22.00
-834K
2
$161.34M